XML 39 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Current Assets:    
Cash and cash equivalents $ 140,296 $ 79,790
Marketable investments (Note 4)   54,333
Accounts receivable, net (Note 13) 67,318 70,023
Deferred commissions 15,677 13,731
Prepaid expenses and other current assets 12,802 18,942
Total current assets 236,093 236,819
Property and equipment, net (Note 13) 22,005 25,249
Goodwill (Note 3) 85,165 76,169
Intangible assets, net (Note 3) 4,951 732
Other assets 5,310 6,231
Total assets 353,524 345,200
Current Liabilities:    
Accounts payable 588 217
Accrued expenses and other current liabilities (Note 13) 54,065 49,629
Deferred revenue 135,332 145,207
Total current liabilities 189,985 195,053
Non-current liabilities 11,939 8,958
Total liabilities 201,924 204,011
Commitments (Note 8)
Stockholders' Equity (Note 9):    
Preferred stock, $0.01 par value Authorized - 500 shares; issued and outstanding - none
Common stock, $0.01 par value Authorized - 125,000 shares Issued - 22,951 and 22,432 shares as of December 31, 2018 and 2017, respectively Outstanding - 18,320 and 18,041 shares as of December 31, 2018 and 2017, respectively 230 224
Additional paid-in capital 200,696 181,910
Retained earnings 127,717 123,010
Treasury stock - 4,631 and 4,391 shares as of December 31, 2018 and 2017, respectively, at cost (171,889) (161,943)
Accumulated other comprehensive loss (5,154) (2,012)
Total stockholders’ equity 151,600 141,189
Total liabilities and stockholders’ equity $ 353,524 $ 345,200